Résumé
Polycystic Ovary Syndrome (PCOS) is a frequent hormonal disorder in women of reproductive age, which is characterized by irregular and rare menstrual cycles or even high levels of androgens. In women with PCOS, the possibility of various complications increases, including infertility. The main purpose of the review was to provide more information on the relationship between PCOS and infertility and highlight the most important evidence-based recommendations on diagnosis and efficient treatment for PCOS. This review includes the most recent literature sources such as clinical trials, systematic reviews, and meta-analyses (from 2019 to 2022) searched in Web of Science and PubMed databases using terms such as ‘Polycystic Ovary Syndrome’ and ‘infertility’. Articles that did not primarily address PCOS and infertility or those that were just in the pilot trial stage were not included in the review. Based on the literature, infertility is one of the main complications of PCOS, which has been reported in 40% of these cases. According to several evidence-based studies the diagnosis of infertility in PCOS women can be achieved according to the Rotterdam criteria based on the level of anti-Mullerian Hormones, FSH, LH, prolactin, estradiol, and testosterone. Options for management or control of infertility disorders in women with PCOS include stimulation of ovulation, intrauterine insemination as well as cycles of assisted reproductive techniques. On the other hand, the most effective treatments for women with PCOS include the use of metformin, letrozole, and minimally invasive laparoscopic techniques. Nevertheless, because the etiology of PCOS is unknown in most patients, therapy is not always successful. Future studies that concentrate on lifestyle factors and any other external variables that may favorably impact the attainment of suitable therapy are required to provide PCOS patients with appropriate and effective treatment.
Références
Abbott, D. H., Dumesic, D. A., & Levine, J. E. (2019). Hyperandrogenic origins of polycystic ovary syndrome–implications for pathophysiology and therapy. Expert Review Of Endocrinology & Metabolism, 14(2), 131-143.
Barry, J. A., Azizia, M. M., & Hardiman, P. J. (2014). Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update, 20(5), 748-758.
Basirat, Z., Faramarzi, M., Chehrazi, M., Amiri, M., Ghofrani, F., & Tajalli, Z. (2020). Differences between infertile women with and without PCOS in terms of anxiety, coping styles, personality traits, and social adjustment: a case–control study. Archives of Gynecology and Obstetrics, 301, 619-626.
Braun, M. M., Overbeek-Wager, E. A., & Grumbo, R. J. (2016). Diagnosis and management of endometrial cancer. American Family Physician, 93(6), 468-474.
Collée, J., Mawet, M., Tebache, L., Nisolle, M., & Brichant, G. (2021). Polycystic ovarian syndrome and infertility: overview and insights of the putative treatments. Gynecological Endocrinology, 37(10), 869-874.
Cunha, A., & Póvoa, A. M. (2021). Infertility management in women with polycystic ovary syndrome: a review. Porto Biomedical Journal, 6(1), e116.
Deshpande, P. S., & Gupta, A. S. (2019). Causes and prevalence of factors causing infertility in a public health facility. Journal of Human Reproductive Sciences, 12(4), 287-293.
Evliyaoglu, O., Imöhl, M., Weiskirchen, R., & van Helden, J. (2020). Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome. Clinical Chemistry and Laboratory Medicine (CCLM), 58(8), 1291-1301.
Heidarzadehpilehrood, R., Pirhoushiaran, M., Abdollahzadeh, R., Binti Osman, M., Sakinah, M., Nordin, N., & Abdul Hamid, H. (2022). A review on CYP11A1, CYP17A1, and CYP19A1 polymorphism studies: candidate susceptibility genes for polycystic ovary syndrome (PCOS) and infertility. Genes, 13(2), 302.
Hoeger, K. M., Dokras, A., & Piltonen, T. (2021). Update on PCOS: consequences, challenges, and guiding treatment. The Journal of Clinical Endocrinology & Metabolism, 106(3), e1071-e1083.
Ignatov, A., & Ortmann, O. (2020). Endocrine risk factors of endometrial cancer: polycystic ovary syndrome, oral contraceptives, infertility, tamoxifen. Cancers, 12(7), 1766.
Jahan, Z., & Wing, K. E. (2021). Polycystic Ovary Syndrome and its Relationship with Infertility and its Management. Journal of Bangladesh College of Physicians & Surgeons, 39(1).
Khmil, M., Khmil, S., & Marushchak, M. (2020). Hormone imbalance in women with infertility caused by polycystic ovary syndrome: is there a connection with body mass index? Open Access Macedonian Journal of Medical Sciences, 8(B), 731-737.
Li, H. W. R., He, Y. L., Li, R., Wong, C. Y. G., Sy, B., Lam, C. W., ... & Ng, E. H. Y. (2020). Age‐specific reference ranges of serum anti‐müllerian hormone in healthy women and its application in diagnosis of polycystic ovary syndrome: a population study. BJOG: An International Journal of Obstetrics & Gynaecology, 127(6), 720-728.
Li, M., Ruan, X., & Mueck, A. O. (2022). Management strategy of infertility in polycystic ovary syndrome. Global Health Journal, 6(2), 70-74.
Louwers, Y. V., & Laven, J. S. (2020). Characteristics of polycystic ovary syndrome throughout life. Therapeutic Advances in Reproductive Health, 14, 2633494120911038.
Mohammed, Z. I., & Qasim, M. T. (2021). Correlation of AMH and LH levels in PCOS patients with pregnancy rate. Annals of the Romanian Society for Cell Biology, 945-951.
Moini, A., Rezaee, T., Aleyasin, A., Arabipoor, A., & Moayed, M. E. (2022). The effect of metabolic syndrome on controlled ovarian stimulation outcome in infertile women with polycystic ovary syndrome undergoing assisted reproductive technology cycles. Archives of Endocrinology and Metabolism, 67, 111-118.
Mukerjee, N. (2020). Polycystic Ovary Syndrome (PCOS) symptoms, causes & treatments-a review. International Journal of Science and Research, 9(7), 1949-1957.
Murugappan, G., Li, S., Lathi, R. B., Baker, V. L., & Eisenberg, M. L. (2019). Risk of cancer in infertile women: analysis of US claims data. Human Reproduction, 34(5), 894-902.
Park, J. C., Lim, S. Y., Jang, T. K., Bae, J. G., Kim, J. I., & Rhee, J. H. (2011). Endometrial histology and predictable clinical factors for endometrial disease in women with polycystic ovary syndrome. Clinical and Experimental Reproductive Medicine, 38(1), 42.
Penzias, A., Azziz, R., Bendikson, K., Cedars, M., Falcone, T., Hansen, K., ... & Yauger, B. (2021). Fertility evaluation of infertile women: a committee opinion. Fertility and Sterility, 116(5), 1255-1265.
Rudnicka, E., Duszewska, A. M., Kucharski, M., Tyczyński, P., & Smolarczyk, R. (2022). Oxidative stress and reproductive function: oxidative stress in polycystic ovary syndrome. Reproduction, 164(6), F145-F154.
Szamatowicz, M., & Szamatowicz, J. (2020). Proven and unproven methods for diagnosis and treatment of infertility. Advances in Medical Sciences, 65(1), 93-96.
Taebi, M., Kariman, N., Montazeri, A., & Majd, H. A. (2021). Infertility stigma: A qualitative study on feelings and experiences of infertile women. International Journal Of Fertility & Sterility, 15(3), 189.
Wang, L., Luo, X., Wang, Q., Lv, Q., Wu, P., Liu, W., & Chen, X. (2021). Fertility-preserving treatment outcome in endometrial cancer or atypical hyperplasia patients with polycystic ovary syndrome. Journal of Gynecologic Oncology, 32(5).
Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019). Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. Journal of the Endocrine Society, 3(8), 1545-1573.
Zehravi, M., Maqbool, M., & Ara, I. (2022). Polycystic ovary syndrome and infertility: an update. International Journal of Adolescent Medicine and Health, 34(2), 1-9.
Ce travail est disponible sous licence Creative Commons Attribution - Pas d’Utilisation Commerciale 4.0 International.